Topography Health is a technology company.
Topography Health has raised $28.0M across 2 funding rounds.
Topography Health has raised $28.0M in total across 2 funding rounds.
Topography Health has raised $28.0M in total across 2 funding rounds.
Topography Health's investors include 75 & Sunny, Andreessen Horowitz, Asset Management Ventures, Bonfire Ventures, CRV, Giant Ventures, Greylock, Optum Ventures, O'Reilly AlphaTech Ventures, Rainfall Ventures, SJF Ventures, SoftBank Investment Advisers.
Topography Health is a technology platform that reinvents clinical research by enabling community physicians to conduct clinical trials efficiently.[1][2][3] Founded in 2020 and headquartered in Los Angeles, it provides a full-stack solution—including digital workflows, data analytics, patient recruitment, and tailored staffing—to help physicians scale trials, unlock new therapies, and generate revenue while expanding patient access to studies.[1][2] The company serves physicians, life sciences companies, and patients in the healthcare sector, addressing barriers like administrative burdens and limited trial participation in diverse communities.[1][3] It has raised $27.35M total, with a $21.5M Series A in 2022 led by Bain Capital Ventures, achieving Series A stage with steady growth in digital health.[1][2]
Topography Health emerged from a personal health challenge faced by co-founder and CEO Alexander Saint-Amand, whose mother's undiagnosed illness prompted him to seek expert medical opinions, inspiring him to found GLG (Gerson Lehrman Group).[3] There, he built the world's largest network of over 200,000 physicians and scientists, fielding thousands of patient inquiries about clinical trials that highlighted access gaps and low physician involvement.[2][3] In 2020, Saint-Amand partnered with co-founders Mac Parish (Product) and Andrew Kirchner to launch Topography, exiting stealth in 2022 with $27.5M in funding led by Bain Capital Ventures and Andreessen Horowitz.[2][3] Early traction built on Saint-Amand's network expertise, focusing on empowering community physicians amid pandemic-driven research needs.[2][3]
Topography stands out in clinical trials through its physician-centric, full-stack approach:
Topography rides the digital health wave, transforming clinical trials amid rising demand for faster, more inclusive research post-pandemic.[1][3] Its timing aligns with market shifts toward decentralized trials, data infrastructure, and community-based enrollment, fueled by needs for diverse patient data and revenue for cash-strapped practices.[1][2] By partnering physicians with life sciences, it counters academic center dominance, influences ecosystem access—especially for overlooked communities—and supports trends like AI in patient matching and risk-based monitoring.[1][3] This positions it within 11,000+ digital health innovators, amplifying evidence generation for sponsors while boosting physician capabilities.[1]
Topography is primed to expand its physician network and platform amid growing clinical trial digitization, potentially capturing more of the $50B+ market as regulations favor decentralized models.[1][2] Trends like AI-enhanced recruitment and global trial diversification will shape its path, with opportunities in partnerships and international scaling via backers like Bain Capital.[2][4] Its influence may evolve from U.S. community enabler to global research disruptor, unlocking therapies faster—echoing its origins in bridging patient needs to expert networks for broader healthcare impact.[3]
Topography Health has raised $28.0M across 2 funding rounds. Most recently, it raised $22.0M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $22.0M Series A | 75 & Sunny, Andreessen Horowitz, Asset Management Ventures, Bonfire Ventures, CRV, Giant Ventures, Greylock, Optum Ventures, O'Reilly AlphaTech Ventures, Rainfall Ventures, SJF Ventures, SoftBank Investment Advisers, Tribe Capital, Two Sigma Ventures, Amit Mukherjee, Anne Wojcicki, Eric Wu, Halle Tecco, Ted Serbinski | |
| May 1, 2020 | $6.0M Seed | Ted Serbinski |